Clinical Pharmacology of Paracetamol in Neonates: A Review

Current Therapeutic Research - Clinical and Experimental

Volumn 77, Issue , 2015, Pages 24-30

  Pacifici, Gian Maria ^a   Allegaert, Karel ^b  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Dosing; Glucuronidation; Metabolism; Neonate; Paracetamol; Sulfation

Indexed keywords

GLUCURONIC ACID; LIVER ENZYME; PARACETAMOL; PLACEBO; SULFATE;

ABNORMAL LABORATORY RESULT; ANALGESIA; ATOPY; BLOOD PRESSURE; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG INDICATION; DRUG MECHANISM; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; DRUG TOLERABILITY; FEVER; HEART RATE; HUMAN; HYPOGLYCEMIA; HYPOTENSION; LIVER FAILURE; LIVER TOXICITY; LOADING DRUG DOSE; NEWBORN CARE; PAIN; PATENT DUCTUS ARTERIOSUS; PREMATURITY; PRIORITY JOURNAL; REVIEW;

EID: 84922353903     PISSN: 0011393X     EISSN: 18790313     Source Type: Journal    
DOI: 10.1016/j.curtheres.2014.12.001     Document Type: Review

References (69)

1. Prescott L.F. Paracetamol. A critical bibliographic review 2001, Taylor and Francis publishers, London. Second edition.
2. Cuzzolin L., Antonucci R., Fanos V. Paracetamol (acetaminophen) efficacy and safety in the newborn. Curr Drug Metab 2013, 14:178-185.
3. Duggan S.T., Scott L.J. Intravenous paracetamol (acetaminophen). Drugs 2009, 69:101-113.
4. Miller R.P., Roberts R.J., Fisher L.J. Acetaminophen elimination kinetics in neonates, children and adults. Clin Pharmacol Ther 1976, 19:284-294.
5. Anderson B.J., van Lingen R.A., Hansen T.G., Lin Y.C., Holford N.H. Acetaminophen developmental pharmacokinetics in premature neonates and infants: a pooled population analysis. Anesthesiology 2002, 96:1336-1345.
6. Anderson B.J., Pons G., Autret-Leca E., Allegaert K., Boccard E. Pediatric intravenous paracetamol (propacetamol) pharmacokinetics: a population analysis. Paediatr Anaesth 2005, 15:282-292.
7. Allegaert K., Vanhaesebrouck S., Verbesselt R., van den Anker J.N. In vivo glucuronidation activity of drugs in neonates: extensive interindividual variability despite their young age. Ther Drug Monit 2009, 31:411-415.
8. Allegaert K., Palmer G.M., Anderson B.J. The pharmacokinetics of intravenous paracetamol in neonates: size matters most. Arch Dis Child 2011, 96:575-580.
9. vanLingen R.A., Deinum J.T., Quak J.M., Kuizenga A.J., vanDam J.G., Anand K.J., Tibboel D., Okken A. Pharmacokinetics and metabolism of rectally administered paracetamol in preterm neonates. Arch Dis Child Fetal Neonatal Ed 1999, 80:F59-F63.
10. Young T.E. Neofax 2011, Thomson Reuters, Montvale, NJ, USA. Twenty-fourth Edition.
11. British National Formulary for children, 2011-2012 2011, BMJ group, The Royal Pharmaceutical Society of Great Britain, London, UK.
12. Neonatal Formulary. Drug use in pregnancy and the first year of life. 6th Edition, BMJ books, Wiley-Blackwell, 2011.
13. Nederlands Kenniscentrum Farmacotherapie bij kinderen. Kinderformularium. Accessed November 01, 2014. http://www.kinderformularium.nl.
14. Allegaert K., Murat I., Anderson B.J. Not all intravenous paracetamol formulations are created equal. Paediatr Anaesth 2007, 17:811-812.
15. Bartocci M., Lundeberg S. Intravenous paracetamol: the 'Stockholm protocol' for postoperative analgesia of term and preterm neonates. Paediatr Anaesth 2007, 17:1120-1121.
16. Allegaert K., Verbesselt R., Naulaers G., et al. Developmental pharmacology: neonates are not just small adult. Acta Clin Belg 2008, 63:16-24.
17. Kearns G.L., Abdel-Rahman S.M., Alander S.W., Blowey D.L., Leeder J.S., Kauffman R.E. Developmental pharmacology--drug disposition, action, and therapy in infants and children. N Engl J Med 2003, 349:1157-1167.
18. Allegaert K., Van der Marel C.D., Debeer A., Pluim M.A., Van Lingen R.A., Vanhole C., Tibboel D., Devlieger H. Pharmacokinetics of single dose intravenous propacetamol in neonates: effect of gestational age. Arch Dis Child Fetal Neonatal Ed 2004, 89:F25-F28.
19. Allegaert K., Anderson B.J., Naulaers G., et al. Intravenous paracetamol (propacetamol) pharmacokinetics in term and preterm neonates. Eur J Clin Pharmacol 2004, 60:191-197.
20. Van Ganzewinkel C., Derijks L., Anand K.J., et al. Multiple intravenous doses of paracetamol result in a predictable pharmacokinetic profile in very preterm infants. Acta Paediatr 2014, 103:612-617.
21. Cook SF, Sherwin CM, Williams EF, et al. Population pharmacokinetics of intravenous acetaminophen in preterm and term neonates [abstract]. American Conference on Pharmacometrics, annual meeting, Las Vegas, Nevada, 11-17 October 2014.
22. Levy G., Khanna N.N., Soda D.M., Tsuzuki O., Stern L. Pharmacokinetics of acetaminophen in the human neonate: formation of acetaminophen glucuronide and sulfate in relation to plasma bilirubin concentration and D-glucaric acid excretion. Pediatrics 1975, 55:818-825.
23. Allegaert K., de Hoon J., Verbesselt R., Vanhole C., Devlieger H., Tibboel D. Intra- and interindividual variability of glucuronidation of paracetamol during repeated administration of propacetamol in neonates. Acta Paediatr 2005, 94:1273-1279.
24. van der Marel C.D., Anderson B.J., van Lingen R.A., Holford N.H., Pluim M.A., Jansman F.G., van den Anker J.N., Tibboel D. Paracetamol and metabolite pharmacokinetics in infants. Eur J Clin Pharmacol 2003, 59(3):243-251.
25. Meremikwu U., Oyo-Ita A. Paracetamol for treating fever in children. Cochrane Database Syst Rev 2002, CD003676.
26. Hopchet L., Kulo A., Rayyan M., et al. Does intravenous paracetamol administration affect body temperature in neonates ?. Arch Dis Child 2011, 96:301-304.
27. Richardson J., Sills J. Hypothermia following fever. Arch Dis Child 2004, 89:1177.
28. De Maat M.M., Tijssen T.A., Brüggemann R.J., Ponssen H.H. Paracetamol for intravenous use in medium- and intensive care patients: pharmacokinetics and tolerance. Eur J Clin Parmacol 2010, 66:713-719.
29. Van den Anker J.N., Tibboel D. Pain relief in neonates: when to use intravenous paracetamol?. Arch Dis Child 2011, 96:573-574.
30. Shah V., Taddio A., Ohlsson A. Randomised controlled trial of paracetamol for heel prick pain in neonates. Arch Dis Child Fetal Neonatal Ed 1998, 79:F209-F211.
31. Howard C.R., Howard F.M., Weitzman M.L. Acetaminophen analgesia in neonatal circumcision: the effect on pain. Pediatrics 1994, 93:641-646.
32. Van Lingen R.A., Quak C.M., Deinum H.T., et al. Effects of rectally administered paracetamol on infants delivered by vacuum extraction. Eur J Obstet Gynecol Reprod Biol 2001, 94:73-78.
33. Tinner E.M., Hoesli I., Jost K., et al. Rectal paracetamol in newborn infants after assisted vaginal delivery may increase pain response. J Pediatr 2013, 162:62-66.
34. Allegaert K., Naulaers G., Vanhaesebrouck S., Anderson B.J. The paracetamol concentration-effect relation in neonates. Paediatr Anaesth 2013, 23:45-50.
35. Anderson B.J., Woollard G.A., Holford N.H. Acetaminophen analgesia in children: placebo effect and pain resolution after tonsillectomy. Eur J Clin Pharmacol 2001, 57:559-569.
36. Veyckemans F., Anderson B.J., Wolf A.R., Allegaert K. Intravenous paracetamol dosage in the neonate and small infant. Br J Anaesth 2014, 112:380-381.
37. Ceelie I., de Wildt S.N., van Dijk M., et al. Effect of intravenous paracetamol on postoperative morphine requirements in neonates and infants undergoing major noncardiac surgery: a randomized controlled trial. JAMA 2013, 309:149-154.
38. Remy C., Marret E., Bonnet F. Effects of acetaminophen on morphine side-effects and consumption after major surgery: meta-analysis of randomized controlled trials. Br J Anaesth 2005, 94:505-513.
39. McGill M.R., Jaeschke H. Mechanistic biomarkers in acetaminophen-induced hepatotoxity and acute liver failure: from preclinical models to patients. Expert Opin Drug Metab Toxicol 2014, 10:1005-1017.
40. Allegaert K., Rayyan M., De Rijdt T., Van Beek F., Naulaers G. Hepatic tolerance of repeated intravenous paracetamol administration in neonates. Paediatr Anaesth 2008, 18:388-392.
41. Isbister G.K., Bucens I.K., Whyte I.M. Paracetamol overdose in a preterm neonate. Arch Dis Child Fetal Neonatal Ed 2001, 85:F70-F72.
42. De la Pintiére A., Beuchée A., Bétrémieux P.E. Intravenous propacetamol overdose in a term newborn. Arch Dis Child Fetal Neonatal Ed 2003, 88:F351-F352.
43. Walls L., Baker C.F., Sarkar S. Acetaminophen-induced hepatic failure with encephalopathy in a newborn. J Perinatol 2007, 27:133-135.
44. Nevin D.G., Shung J. Intravenous paracetamol overdose in a preterm infant during anesthesia. Paediatr Anaesth 2010, 20:105-107.
45. Medicines and Healthcare products regulatory agency. Drug Safety Update. 2010;3:1-4.
46. Porta R., Sanchez L., Nicolas M., Garcia C., Martinez M. Lack of toxicity after paracetamol overdose in a extremely preterm neonate. Eur J Clin Pharmacol 2012, 68:901-902.
47. Campbell S., Engelhardt T., McLay J., Anderson B. Potentially life-threatening intravenous acetaminophen overdose in a 3 month old (40 weeks' postmenstrual age) 2.3 kg baby girl. Open J Pediatr 2013, 186-187.
48. Bucaretchi F., Fernandes C.B., Branco M.M., et al. Acute liver failure in a term neonate after repeated paracetamol administration. Rev Paul Pediatr 2014, 32:144-148.
49. Allegaert K., Naulaers G. Haemodynamics of intravenous paracetamol in neonates. Eur J Clin Pharmacol 2010, 66:855-858.
50. Bhattacharyya S., Yan K., Pence L., et al. Targeted liquid chromatography-mass spectrometry analysis of serum acylcarnitines in acetaminophen toxicity in children. Biomark Med 2014, 8:147-159.
51. James L.P., Chiew A., Abdel-Rahman S.M., et al. Acetaminophen protein adduct formation following low-dose acetaminophen exposure: comparison of immediate-release vs extended-release formulations. Eur J Clin Pharmacol 2013, 69:851-857.
52. James L.P., Alonso E.M., Hynan L.S., et al. Detection of acetaminophen protein adducts in children with acute liver failure of indeterminate cause. Pediatrics 2006, 118:e676-e681.
53. James L.P., Capparelli E.V., Simpson P.M., et al. Acetaminophen-associated hepatic injury: evaluation of acetaminophen protein adducts in children and adolescents with acetaminophen overdose. Clin Pharmacol Ther 2008, 84:684-690.
54. Lowe A.J., Carlin J.B., Bennett C.M., et al. Paracetamol use in early life and asthma: prospective birth cohort study. BMJ 2010, 341:c4616.
55. Farquhar H., Crane J., Mitchell E.A., Eyers S., Beasley R. The acetaminophen and asthma hypothesis 10 years on: a case to answer. J Allergy Clin Immunol 2009, 124:649-651.
56. Wickens K., Beasley R., Town I., et al. The effects of early and late paracetamol exposure on asthma and atopy: a birth cohort. Clin Exp Allergy 2011, 41:399-406.
57. Holgate S.T. The acetaminophen enigma in asthma. Am J Respir Crit Care Med 2011, 183:147-148.
58. Shaheen S.O., Newson R.B., Ring S.M., et al. Prenatal and infant acetaminophen exposure, antioxidant gene polymorphisms, and childhood asthma. J Allergy Clin Immunol 2010, 126. 1141-8.e7.
59. Kang S.H., Jung Y.H., Kim H.Y., et al. Effect of paracetamol use on the modification of the development of asthma by reactive oxygen species genes. Ann Allergy Asthma Immunol 2013, 111:580.
60. Riley J., Braithwaite I., Shirtcliffe P., et al. Randomized controlled trial of asthma risk with paracetamol use in infancy - a feasibility study. Clin Exp Allergy 2014, 10.1111/cea.12433.
61. Abdel-Hady J., Nasef N., Shabaan A.E., Nour I. Patent ductus arteriosus in preterm infants: do we have the right answers?. Biomed Res Int 2013, 2013:676192.
62. Allegaert K., Anderson B., Simons S., van Overmeire B. Paracetamol to induce ductus arteriosus closure: is it valid ?. Arch Dis Child 2013, 98:462-466.
63. Hammerman C., Bin-Nun A., Markovitch E., Schimmel M.S., Kaplan M., Fink D. Ductal closure with paracetamol: a surprising new approach to patent ductus arteriosus treatment. Pediatrics 2011, 128:e1617-e1621.
64. Le J., Gales M.A., Gales B.J. Acetaminophen for patent ductus arteriosus. Ann Pharmacother 2014, (pii: 1060028014557564).
65. Roofthooft D.W., van Beynem I.M., Helbing W.A., Reiss I.K., Simons S.H. Paracetamol for ductus arteriosus closure: not always a success story. Concerning the article by M.Y. Oncel et al: intravenous paracetamol treatment in the management of patent ductus arteriosus in extremely low birth weight infants. Neonatology 2013, 104:170.
66. Oncel M.Y., Yurttutan S., Erdeve O., et al. Oral paracetamol versus oral ibuprofen in the management of patent ductus arteriosus in preterm infants: a randomized controlled trial. J Pediatr 2014, 164. 510-514.e1.
67. Dang D., Wang D., Zhang C., Zhou W., Zhou Q., Wu H. Comparison of oral paracetamol versus ibuprofen in premature infants with patent ductus arteriosus: a randomized controlled trial. PLoS One 2013, 8:e77888.
68. Sallmon H., Weber S.C., Hüning B., et al. Thrombocytopenia in the first 24 hours after birth and incidence of patent ductus arteriosus. Pediatrics 2012, 130:e623-e630.
69. El-Khuffash A., Jain A., Corcoran D., et al. Efficacy of paracetamol on patent ductus arteriosus closure may be dose dependent: evidence form human and murine studies. Pediatr Res 2014, 76:238-244.